COMP <GO>
PRPO vs MRK // OPERATING MARGIN
Precipio Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: PRPO 2
— MRK 9
▲ OPERATING MARGIN LEADER: MRK
LAST: $18.10 (-6.46%) • MKT CAP: $34.6M
operating-margins
-5.00%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
operating-margins
34.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRPO VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRPO | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.20% | 74.80% | -30.60 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.90% | 20.70% | -28.60 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.04% | 3.42% | -2.38 | MRK | /fcf-yield <GO> |
| Operating Margin ACTIVE | -5.00% | 34.30% | -39.30 | MRK | /operating-margins <GO> |
| Net Profit Margin | -1.50% | 28.10% | -29.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 30.50% | 1.30% | +29.20 | PRPO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.19 | -4.99 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | PRPO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.2 | 51.7 | -15.50 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $34.6M | $361.02B | -$360.99B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRPO REV | MRK REV | PRPO GROSS % | MRK GROSS % | PRPO FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $24.2M | $65.01B | 44.2% | 74.8% | $359.0K | $12.36B |
| FY 2024 | $18.6M | $64.17B | 40.7% | 76.3% | $216.0K | $18.10B |
| FY 2023 | $15.4M | $60.12B | — | — | -$3.6M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRPO // BETA —
MRK // BETA 0.92